The developments came at a bad time for the optimists of the Indian stock market, after US President Donald Trump made two new strikes of investor confidence, in collaboration with indications of the market recovery. The MSCI India index has declined in all five trading sessions since Trump has signed a decision to restructure the H-1B visa program, a step that threatens to disrupt the $ 280 billion Indian software services. Meanwhile, its plan to impose 100% Customs on brand or patent medicine has resulted in the Indian pharmaceutical businesses being put together into a sharp sale wave that swept the Asian markets on Friday. Also read: Why does Trump want to increase the H-1B visa fees for skilled workers to $ 100,000? The index has recorded an increase over three consecutive weeks, which added more than 4%, in its longest range since May, in its longest range. Fear of foreign investors Trump’s recent movements have destroyed the trust of foreign investors, after it seemed to adapt to 50% US customs imposed on India, which negatively affected the relationship between the two countries. In the aftermath of two weeks of purchase, global funds in the last sessions became a seller of Indian shares. ‘Investment Management’ in Zurich said: ‘The increase in tension between the United States and India is increasing the pressure. He added that ‘the addresses associated with this file are pushing investors to lead their money away from India to markets with a stronger momentum like China and South Korea. ‘In the slowdown in economic growth and the decline in the frequency of corporate profits, Indian stocks have suffered successive wave of rise. which incurred space implementation on September 22, as well as the central bank, and the expectations that the resumption of commercial negotiations with the United States will lead to positive results. Performance since April. Level Tuesday, the concern of India’s execution of India, in addition to commodity exports already suffering from customs duties, is also: The Indian Rupee countries to a record level amid the concern of US fees, and the pharmaceutical business index has dropped more than 2% on Friday, which has imposed the worst. Givekal research, wrote in a note: ‘It seems that the execution of Indian origin will continue. The more 5%long, the more disappointment in the growth of the Indian economy. “In the same context, foreign funds sold Indian shares with a net worth about $ 16 billion during 2025, which placed the market in the field of registration, the second largest outflow ever after a record $ 17 billion withdrawal in 2022. Without the strong purchases of shares in Asia, the market performance would have been this year. Expectations of profit growth are a little drop, the judgments are no longer a concern, and the government policies have become a supporting factor for shares, and most foreign funds maintain limited investment centers. -The prospects for the Indian stock markets, especially with regard to foreign flow, will remain onopolitical factors. The shares rose for the first time in a month this week as it closed an indicator that measures the UPS of the next thirty days on the national stock exchange for 50 days for 50 days, indicating that traders are preparing for more market fluctuations.
Trump shocked the interest of the Indian stock market recovery
